title: Dapsone in the management of autoimmune bullous diseases.
abstract: Dapsone is used in the treatment of autoimmune bullous diseases (AIBD), a group of disorders resulting from autoimmunity directed against basement membrane and/or intercellular adhesion molecules on cutaneous and mucosal surfaces. This review summarizes the limited published data evaluating dapsone as a therapy for AIBD.
authors.affiliation: Department of Dermatology, Perelman Center for Advanced Medicine, Suite 1-330A, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.
authors.forename: Evan W
authors.initials: EW
authors.lastname: Piette
authors.forename: Victoria P
authors.initials: VP
authors.lastname: Werth
mesh_terms: D001327:Autoimmune Diseases / Q000188:drug therapy*; D003622:Dapsone / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy*
chemical_list: D003879:Dermatologic Agents; D005493:Folic Acid Antagonists; D007166:Immunosuppressive Agents; D003622:Dapsone